View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
November 4, 2009

Aureus Renews Database Agreement With Sanofi-Aventis R&D

Aureus Pharma has extended its knowledge database agreement with Sanofi-Aventis research & development for additional three-years.

By CBR Staff Writer

Under the agreement, Aureus will provide AurSCOPE knowledge databases and continue to update existing databases for Sanofi-Aventis’ R&D division. These databases are expected to give Sanofi-Aventis researchers access to information on major therapeutic targets.

The therapeutic targets include G protein-coupled receptor, protein receptors, nuclear receptors, kinase inhibitors, ion channels, as well as information relative to drug safety including data on absorption, distribution, metabolism, and excretion.

The new agreement reinforces the relationship between Aureus Pharma and Sanofi-Aventis, which has been in existence for the last seven years. It also secures additional revenues for Aureus over the next three years.

Jason Theodosiou, CEO of Aureus Pharma, said: Sanofi-aventis’ decision to extend the partnership for an additional three year period, as well as to acquire new knowledge bases, confirms the fact that Aureus´ products are meeting the needs of the world´s leading pharmaceutical companies.

Content from our partners
Sherif Tawfik: The Middle East and Africa are ready to lead on the climate
What to look for in a modern ERP system
How tech leaders can keep energy costs down and meet efficiency goals

Topics in this article :
Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.